StemCells, Inc. (STEM) Supports National Neurotechnology Initiative Act
StemCells, Inc. (NASDAQ:STEM), a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell-based therapeutics to treat diseases of the central nervous system and liver, recently announced the company’s support of the National Neurotechnology Inititative Act, an initiative to foster new discoveries and accelerate the development of new and safer treatments for brain-related injuries or diseases. Recently introduced by a bipartisan group of members of both houses of Congress, the National Neurotechnology Inititative Act aims to fast track the development of scientific discoveries into actual products or treatments by improving neuroscience research coordination among various Federal agencies. This…